Skip to Main content Skip to Navigation
New interface
Journal articles

Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death

Abstract : Multiple myeloma (MM) is a common hematological disease characterized by the accumulation of clonal malignant plasma cells in the bone marrow. Over the past two decades, new therapeutic strategies have significantly improved the treatment outcome and patients survival. Nevertheless, most MM patients relapse underlying the need of new therapeutic approaches. Plasma cells are prone to produce large amounts of immunoglobulins causing the production of intracellular ROS. Although adapted to high level of ROS, MM cells die when exposed to drugs increasing ROS production either directly or by inhibiting antioxidant enzymes. In this review, we discuss the efficacy of ROS-generating drugs for inducing MM cell death and counteracting acquired drug resistance specifically toward proteasome inhibitors.
Complete list of metadata
Contributor : Brigitte Sola Connect in order to contact the contributor
Submitted on : Thursday, May 20, 2021 - 5:07:17 PM
Last modification on : Friday, March 11, 2022 - 6:14:02 PM
Long-term archiving on: : Saturday, August 21, 2021 - 6:56:02 PM


Caillot Cancers 2021.pdf
Publisher files allowed on an open archive



Mélody Caillot, Hassan Dakik, Frédéric Mazurier, Brigitte Sola. Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death. Cancers, 2021, 13 (10), pp.2411. ⟨10.3390/cancers13102411⟩. ⟨hal-03231403⟩



Record views


Files downloads